MedTrace Logo

Brief Digital CBT for Mood and Anxiety Symptoms in Acute Psychiatric Inpatients

NCT04841603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-07-27

No results posted yet for this study

Summary

A randomized control trial examining the feasibility, acceptability, and preliminary efficacy of providing access to the MindShift CBT mobile app via tablet for acute psychiatric inpatients.

Conditions

  • Anxiety
  • Depressive Symptoms
  • Distress, Emotional
  • Anxiety and Fear
  • Anxiety State
  • Mental Disorders, Severe
  • Psychiatric Hospitalization

Interventions

DEVICE

Mindshift CBT

A tablet with the Mindshift CBT app installed. Mindshift CBT is a free, evidence based app developed by Anxiety Canada, designed to help users reduce symptoms of anxiety and distress.

DEVICE

Treatment as Usual

Treatment as usual. A tablet identical to the intervention group, but without the Mindshift CBT app is available for patients to use during their inpatient stay.

Sponsors & Collaborators

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • Ishrat Husain, MBBS, MD (Res.), MRCPsych · Centre for Addiction and Mental Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2021-05-11
Completion
2021-05-11

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04841603 on ClinicalTrials.gov